Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax

NCT07691047 is registered in ClinicalTrials.gov with Private Hospital of Confluent, France as lead sponsor.

NCT NCT07691047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07691047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax
Lead sponsor
Private Hospital of Confluent, France
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2026
Completion date
September 30, 2029
Enrollment
130 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphoid leukemia